T Glip-M 1000 Tablet ER is a combination of two medicines: Glimepiride and Metformin. Glimepiride stimulates the pancreas to produce more insulin, and Metformin improves the sensitivity of muscle cells to insulin. Together, they help control blood sugar levels.

T Glip-M 1000 Tablet ER begins to lower blood sugar levels shortly after ingestion. However, it may take several weeks to achieve the full effect. Monitor your blood sugar levels as recommended by your doctor.

Yes, T Glip-M 1000 Tablet ER can lower blood sugar levels, which may lead to hypoglycemia, especially if meals are skipped or delayed, or if taken with other diabetes medications that also lower blood sugar. Symptoms of hypoglycemia include sweating, shakiness, dizziness, hunger, and confusion. Follow your doctor's instructions to prevent and manage hypoglycemia.

Yes, T Glip-M 1000 Tablet ER can be used in elderly patients with type 2 diabetes mellitus. However, dosage adjustments may be necessary based on kidney function and overall health. Elderly patients may be more susceptible to certain side effects and should be monitored closely.

While T Glip-M 1000 Tablet ER itself does not directly cause vitamin B12 deficiency, Metformin (one of its components) can reduce vitamin B12 absorption over time. Regular monitoring of vitamin B12 levels and supplementation may be recommended by your doctor.